Investors

A binding document of principles was signed between Rekah’s subsidiary Vitamad and Teva Pharmaceuticals. Teva will transfer the manufacturing rights for several prescription drugs, OTC drugs and hospital antiseptic products to Vitamed, which will supply them exclusively to Teva.